Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGM | P11217 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6756889 | 0.98 | PYGM (0.33) | PYGM | |
| SCHEMBL5349801 | 0.86 | — | — | |
| SCHEMBL19895294 | 0.73 | — | — | |
| SCHEMBL346177 | 0.73 | KDM4E (0.30) | — | |
| SCHEMBL6423801 | 0.71 | — | — | |
| SCHEMBL11312340 | 0.69 | — | — | |
| SCHEMBL13865281 | 0.69 | — | — | |
| SCHEMBL11112516 | 0.67 | NPC1 (0.33) | — | |
| SCHEMBL6005139 | 0.66 | — | — | |
| SCHEMBL19952738 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6706528-B2 | DETECTING MAGNESIUM ION WITH A CARBOXY-QUINOLIZINE COMPOUND TO FORM A COMPLEX AND DETECTING FLUORESCENCE IN SAID COMPLEX; FOR DIAGNOSIS OF CARDIOVASCULAR DISEASES | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2004-03-16 | — | — | US | claimed |
| US-20020031834-A1 | Fluorescent magnesium indicators | THE GOVERNMENT OF THE UNITED STATES | 2002-03-14 | — | — | US | claimed |
| EP-1144415-A2 | FUNCTIONALIZED HETEROCYCLES AS CHEMOKINE RECEPTOR MODULATORS | WARNER-LAMBERT COMPANY (US) | 2001-10-17 | — | — | EP | claimed |
| WO-2000042045-A2 | FUNCTIONALIZED HETEROCYCLES AS CHEMOKINE RECEPTOR MODULATORS | WARNER-LAMBERT COMPANY (US) | 2000-07-20 | — | — | WO | claimed |
| US-6706528-B2 | DETECTING MAGNESIUM ION WITH A CARBOXY-QUINOLIZINE COMPOUND TO FORM A COMPLEX AND DETECTING FLUORESCENCE IN SAID COMPLEX; FOR DIAGNOSIS OF CARDIOVASCULAR DISEASES | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2004-03-16 | — | — | US | disclosed |
| US-6706528-B2 | DETECTING MAGNESIUM ION WITH A CARBOXY-QUINOLIZINE COMPOUND TO FORM A COMPLEX AND DETECTING FLUORESCENCE IN SAID COMPLEX; FOR DIAGNOSIS OF CARDIOVASCULAR DISEASES | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2004-03-16 | — | — | US | disclosed |
| CN-1344270-A | Functionalized heterocycles as chemokine receptor modulators | THOUSAND YEARS MEDICAMENTS INC (US) | 2002-04-10 | — | — | CN | disclosed |
| US-20020031834-A1 | Fluorescent magnesium indicators | THE GOVERNMENT OF THE UNITED STATES | 2002-03-14 | — | — | US | disclosed |
| US-20020031834-A1 | Fluorescent magnesium indicators | THE GOVERNMENT OF THE UNITED STATES | 2002-03-14 | — | — | US | disclosed |
| EP-1144415-A2 | FUNCTIONALIZED HETEROCYCLES AS CHEMOKINE RECEPTOR MODULATORS | WARNER-LAMBERT COMPANY (US) | 2001-10-17 | — | — | EP | disclosed |
| WO-2000042045-A2 | FUNCTIONALIZED HETEROCYCLES AS CHEMOKINE RECEPTOR MODULATORS | WARNER-LAMBERT COMPANY (US) | 2000-07-20 | — | — | WO | disclosed |
| CN-1016871-B | Process for the preparation of bicyclic and tricyclic pyridine derivatives | HOFFMANN LA ROCHE 7 CO F (CN) | 1992-06-03 | — | — | CN | disclosed |
| CN-85108120-A | The preparation of tricyclic pyridine derivative and application thereof | — | 1986-11-05 | — | — | CN | disclosed |